Beyond Spreadsheets: Finally, an Accurate Solution to Trial Forecasting

DURHAM, N.C., August 08, 2016 — It’s one of the most important things to get right in any clinical trial, yet almost nobody does it well. Trial forecasting requires constant pursuit of fast-moving targets, but most efforts are hobbled by manual processes that are slow and ineffective — and it only gets tougher as studies grow more complex.

That’s changing now with the advent of automated trial planning and investigator payment tools, described in a Premier Research and Bioclinica webinar now available on demand. Clinical Trial Forecasting: Managing the Challenges and Avoiding the Fines examines new approaches to forecasting and reforecasting budgets, cash flow, patient enrollment, study amendments, grant payments, and other elements.

In a telling illustration, 60 percent of the webinar’s attendees said 6 percent to 10 percent forecast-versus-actual variations were acceptable in their studies. Those results, typical with the spreadsheet-based processes used on most trials, are too high for presenters Jim Sacchetta and Jay Trepanier. Considering the huge cost of drug development, they target variances no greater than 3 percent — a goal their user-friendly tools are delivering today.

These tools also can quickly model changing scenarios, such as adding new geographic regions — an increasingly common occurrence as trials become more global. View the webinar to get the whole story.

About Premier Research

Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, CNS, oncology, pediatric and rare disease. Premier Research operates in 84 countries and employs 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.

Author Details

Megan Sims
Phone Us Now
Email Us Now